These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16740239)

  • 1. [Markers of airway remodeling in induced sputum from healthy smokers].
    Avilés B; Belda J; Margarit G; Bellido-Casado J; Martínez-Brú C; Casan P
    Arch Bronconeumol; 2006 May; 42(5):235-40. PubMed ID: 16740239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma.
    Chaudhuri R; McSharry C; Brady J; Grierson C; Messow CM; Spears M; Miele G; Nocka K; MacNee W; Connell M; Murchison JT; Sproule M; Hilmi OJ; Miller DK; Thomson NC
    Eur Respir J; 2014 Oct; 44(4):895-904. PubMed ID: 24993912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
    Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study.
    Kwiatkowska S; Noweta K; Zieba M; Nowak D; Bialasiewicz P
    Respiration; 2012; 84(3):231-41. PubMed ID: 22832426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Airway remodeling assessed by high-resolution computed tomography in patients with asthma: relationship to biological markers in induced sputum].
    Wu SM; Li CE; Cai RP; Zhang Q; Xu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Dec; 35(12):892-6. PubMed ID: 23328178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
    Beeh KM; Beier J; Kornmann O; Buhl R
    Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10.
    Beeh KM; Beier J; Kornmann O; Micke P; Buhl R
    J Heart Lung Transplant; 2001 Nov; 20(11):1144-51. PubMed ID: 11704473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.
    Vignola AM; Riccobono L; Mirabella A; Profita M; Chanez P; Bellia V; Mautino G; D'accardi P; Bousquet J; Bonsignore G
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1945-50. PubMed ID: 9847290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study of inflammatory factors in sputum induced early after lung volume reduction surgery.
    Miao JB; Hou SC; Li H; Hu B; Wang TY
    Chin Med J (Engl); 2008 Sep; 121(18):1796-9. PubMed ID: 19080360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma.
    Park HS; Kim HA; Jung JW; Kim YK; Lee SK; Kim SS; Nahm DH
    Clin Exp Allergy; 2003 Jan; 33(1):113-8. PubMed ID: 12534559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD; Kapsner RK; Osberg I
    Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
    Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
    Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
    Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
    Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of matrix metalloproteinase in airway epithelial cells of COPD patients.
    Li W; Xu Y; Zhang Z
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):151-4. PubMed ID: 16116959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
    Ziora D; Dworniczak S; Kozielski J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():809-17. PubMed ID: 19218708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
    Hao W; Li M; Zhang C; Zhang Y; Wang P
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.